Diagnostic yield of screening for SARS-CoV-2 among patients admitted to hospital for alternate diagnoses: an observational cohort study.


Journal

BMJ open
ISSN: 2044-6055
Titre abrégé: BMJ Open
Pays: England
ID NLM: 101552874

Informations de publication

Date de publication:
10 08 2022
Historique:
entrez: 10 8 2022
pubmed: 11 8 2022
medline: 13 8 2022
Statut: epublish

Résumé

To determine the diagnostic yield of screening patients for SARS-CoV-2 who were admitted with a diagnosis unrelated to COVID-19 and to identify risk factors for positive tests. Cohort from the Canadian COVID-19 Emergency Department Rapid Response Network registry. 30 acute care hospitals across Canada. Patients hospitalised for non-COVID-19-related diagnoses who were tested for SARS-CoV-2 between 1 March and 29 December 2020. Positive nucleic acid amplification test for SARS-CoV-2. Diagnostic yield. We enrolled 15 690 consecutive eligible adults who were admitted to hospital without clinically suspected COVID-19. Among these patients, 122 tested positive for COVID-19, resulting in a diagnostic yield of 0.8% (95% CI 0.64% to 0.92%). Factors associated with a positive test included presence of fever, being a healthcare worker, having a positive household contact or institutional exposure, and living in an area with higher 7-day average incident COVID-19 cases. Universal screening of hospitalised patients for COVID-19 across two pandemic waves had a low diagnostic yield and should be informed by individual-level risk assessment in addition to regional COVID-19 prevalence. NCT04702945.

Identifiants

pubmed: 35948378
pii: bmjopen-2021-057852
doi: 10.1136/bmjopen-2021-057852
pmc: PMC9378945
doi:

Banques de données

ClinicalTrials.gov
['NCT04702945']

Types de publication

Journal Article Observational Study Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e057852

Informations de copyright

© Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Références

CMAJ Open. 2021 Mar 17;9(1):E261-E270
pubmed: 33731427
BMJ Open. 2021 Dec 2;11(12):e055832
pubmed: 34857584
CMAJ Open. 2020 Dec 18;8(4):E887-E894
pubmed: 33355274
Ann Emerg Med. 2013 Jun;61(6):605-611.e6
pubmed: 23218508
Obstet Gynecol. 2020 Aug;136(2):283-287
pubmed: 32433448
Cochrane Database Syst Rev. 2020 Jul 7;7:CD013665
pubmed: 32633856
Infect Control Hosp Epidemiol. 2020 Sep;41(9):1095-1096
pubmed: 32456729
Clin Infect Dis. 2021 Jan 22;:
pubmed: 33480973
West J Emerg Med. 2021 May 05;22(3):572-579
pubmed: 34125029
Transpl Infect Dis. 2020 Dec;22(6):e13363
pubmed: 32516847
Am J Perinatol. 2020 Aug;37(10):991-994
pubmed: 32428964
J Bone Joint Surg Am. 2020 Aug 19;102(16):1379-1388
pubmed: 32516279
Resuscitation. 2020 Jun;151:18-23
pubmed: 32283117
N Engl J Med. 2020 May 28;382(22):2163-2164
pubmed: 32283004
Ann Surg. 2020 Dec;272(6):919-924
pubmed: 33021367

Auteurs

Philip Davis (P)

Department of Emergency Medicine, University of Saskatchewan, Saskatchewan, Saskatoon, Canada phil.davis@usask.ca.

Rhonda Rosychuk (R)

Department of Pediatrics, University of Alberta, Edmonton, Alberta, Canada.

Jeffrey P Hau (JP)

Centre for Clinical Epidemiology and Evaluation, Vancouver Coastal Health Research Institute, Vancouver, British Columbia, Canada.
Department of Emergency Medicine, The University of British Columbia, Vancouver, British Columbia, Canada.

Ivy Cheng (I)

Department of Emergency Medicine, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada.
Department of Emergency Medicine, University of Toronto Faculty of Medicine, Toronto, Ontario, Canada.

Andrew D McRae (AD)

Department of Emergency Medicine, University of Calgary, Calgary, Alberta, Canada.

Raoul Daoust (R)

Département Médecine de Famille et Médecine d'Urgence, Université de Montréal, Montreal, Quebec, Canada.

Eddy Lang (E)

Department of Emergency Medicine, University of Calgary, Calgary, Alberta, Canada.

Joel Turner (J)

Department of Emergency Medicine, McGill University, Montreal, Quebec, Canada.

Jaspreet Khangura (J)

Department of Emergency Medicine, Northeast Community Health Centre, Edmonton, Alberta, Canada.

Patrick T Fok (PT)

Department of Emergency Medicine, Dalhousie University, Halifax, Nova Scotia, Canada.

Maja Stachura (M)

Department of Emergency Medicine, The University of British Columbia, Vancouver, British Columbia, Canada.

Baljeet Brar (B)

Department of Emergency Medicine, The University of British Columbia, Vancouver, British Columbia, Canada.

Corinne M Hohl (CM)

Department of Emergency Medicine, The University of British Columbia, Vancouver, British Columbia, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH